Related Experiment Video
Updated: Oct 11, 2025

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.7K
Machine learning, artificial intelligence and the prediction of dementia
Alexander Merkin1, Rita Krishnamurthi1, Oleg N Medvedev2
1Auckland University of Technology, Auckland.
Current Opinion in Psychiatry
|December 3, 2021
Summary
Artificial intelligence (AI) and machine learning (ML) are revolutionizing dementia research for better prediction and diagnostics. These technologies offer a path toward more accurate, standardized, and reproducible understanding and treatment of dementia.
Area of Science:
- Medical Informatics
- Computational Neuroscience
- Artificial Intelligence in Medicine
Background:
- Artificial intelligence (AI) and machine learning (ML) are increasingly integral to medical advancements.
- AI facilitates automated analytical modeling for disease prediction, diagnostics, and treatment planning.
Purpose of the Study:
- To provide an overview of AI applications specifically within dementia research.
- To explore the role of ML and Deep Learning in dementia diagnosis and prediction.
Main Methods:
- Review of current literature on AI and ML applications in dementia.
- Analysis of Deep Learning versus traditional ML methods for dementia detection and prediction.
Main Results:
- Deep Learning models show potential for higher accuracy in dementia detection and prediction compared to traditional ML.
- Limitations include high computational costs for Deep Learning and scarcity of large datasets for training ML models.
- Current commercial applications are limited, primarily to mobile health tools with basic ML functionalities.
Conclusions:
- AI and ML technologies offer significant advantages for psychiatry and neurology in understanding dementia.
- These technologies can lead to more accurate, reproducible, and standardized evidence-based diagnostic and treatment processes.
Related Concept Videos
Dementia
213
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
213
Alzheimer's Disease: Overview
735
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
735
Alzheimer's Disease: Treatment
290
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
290

